Rankings
▼
Calendar
XENE Q2 2023 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
XENE
Xenon Pharmaceuticals Inc.
$5B
Q2 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
$0
Operating Income
-$56M
Net Income
-$47M
EPS (Diluted)
$-0.72
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$33M
Free Cash Flow
-$35M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$685M
Total Liabilities
$38M
Stockholders' Equity
$646M
Cash & Equivalents
$65M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$536,000
-100.0%
Gross Profit
$0
-$22M
+100.0%
Operating Income
-$56M
-$30M
-83.5%
Net Income
-$47M
-$31M
-52.3%
← FY 2023
All Quarters
Q3 2023 →